|
FBXO42 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.77799999962525E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.66570000004196E-06 |
| Normal-vs-Stage2 |
1.2730999999766E-06 |
| Normal-vs-Stage3 |
6.402200E-03 |
| Normal-vs-Stage4 |
1.737530E-03 |
| Stage1-vs-Stage2 |
2.438800E-01 |
| Stage1-vs-Stage3 |
8.556000E-01 |
| Stage1-vs-Stage4 |
8.018800E-01 |
| Stage2-vs-Stage3 |
3.579400E-01 |
| Stage2-vs-Stage4 |
6.927800E-01 |
| Stage3-vs-Stage4 |
7.402800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.5046999996281E-07 |
| Normal-vs-AfricanAmerican |
1.374970E-04 |
| Normal-vs-Asian |
8.027800E-02 |
| Caucasian-vs-AfricanAmerican |
8.018400E-01 |
| Caucasian-vs-Asian |
5.961200E-01 |
| AfricanAmerican-vs-Asian |
6.914200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.77620000321832E-08 |
| Normal-vs-Female |
7.050500E-02 |
| Male-vs-Female |
1.644060E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.545700E-02 |
| Normal-vs-Extreme_Weight |
1.34610000035451E-07 |
| Normal-vs-Obese |
3.22890000004072E-06 |
| Normal-vs-Extreme_Obese |
1.426280E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.702770E-01 |
| Normal_Weight-vs-Obese |
3.004600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.861400E-01 |
| Extreme_Weight-vs-Obese |
6.481400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.082600E-01 |
| Obese-vs-Extreme_Obese |
4.592200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.294400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.60019999999994E-05 |
| Normal-vs-Age(61-80Yrs) |
6.26120000291053E-08 |
| Normal-vs-Age(81-100Yrs) |
1.710729999993E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.134200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.018570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.636400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.673980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.513420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.992000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.63949999973678E-07 |
| Normal-VS-Type2 PRCC |
3.76649999966894E-07 |
| Normal-VS-KIRP CIMP |
8.722600E-01 |
| Normal-VS-Unclassified PRCC |
1.762900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.733450E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.726400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.578000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.862000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.700790E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.240050E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.32030000452733E-08 |
| Normal-vs-N1 |
1.023540E-02 |
| Normal-vs-N2 |
4.678300E-02 |
| N0-vs-N1 |
3.798000E-01 |
| N0-vs-N2 |
6.185000E-01 |
| N1-vs-N2 |
9.602800E-01 |
|
|
